Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy-X04, a Systemically Administered Congo Red Derivative
- 1 September 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 61 (9), 797-805
- https://doi.org/10.1093/jnen/61.9.797
Abstract
The identification of amyloid deposits in living Alzheimer disease (AD) patients is important for both early diagnosis and for monitoring the efficacy of newly developed anti-amyloid therapies. Methoxy-X04 is a derivative of Congo red and Chrysamine-G that contains no acid groups and is therefore smaller and much more lipophilic than Congo red or Chrysamine-G. Methoxy-X04 retains in vitro binding affinity for amyloid beta (Abeta) fibrils (Ki = 26.8 nM) very similar to that of Chrysamine-G (Ki = 25.3 nM). Methoxy-X04 is fluorescent and stains plaques, tangles, and cerebrovascular amyloid in postmortem sections of AD brain with good specificity. Using multiphoton microscopy to obtain high-resolution (1 microm) fluorescent images from the brains of living PSI/APP mice, individual plaques could be distinguished within 30 to 60 min after a single i.v. injection of 5 to 10 mg/kg methoxy-X04. A single i.p. injection of 10 mg/kg methoxy-X04 also produced high contrast images of plaques and cerebrovascular amyloid in PSI/APP mouse brain. Complementary quantitative studies using tracer doses of carbon- 11-labeled methoxy-X04 show that it enters rat brain in amounts that suggest it is a viable candidate as a positron emission tomography (PET) amyloid-imaging agent for in vivo human studies.Keywords
This publication has 46 references indexed in Scilit:
- Synthesis and 11C‐labelling of (E,E)‐1‐(3′,4′‐dihydroxystyryl)‐4‐(3′‐methoxy‐4′‐hydroxystyryl) benzene for PET imaging of amyloid deposits†Journal of Labelled Compounds and Radiopharmaceuticals, 2002
- Structural and Functional Disruption of Vascular Smooth Muscle Cells in a Transgenic Mouse Model of Amyloid AngiopathyThe American Journal of Pathology, 2001
- Regulation of APP cleavage by α‐, β‐ and γ‐secretasesFEBS Letters, 2000
- Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 TransgenesNeurobiology of Disease, 1999
- Microscale Titrimetric and Spectrophotometric Methods for Determination of Ionization Constants and Partition Coefficients of New Drug CandidatesJournal of Pharmaceutical Sciences, 1998
- Relationship between immobilised artificial membrane chromatographic retention and the brain penetration of structurally diverse drugsJournal of Pharmaceutical and Biomedical Analysis, 1997
- Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's diseaseAnnals of Neurology, 1997
- [11C]WAY 100635: A radioligand for imaging 5-HT1A receptors with positron emission tomographyLife Sciences, 1994
- [11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with petLife Sciences, 1993
- Quantitation of Carbon‐11‐labeled raclopride in rat striatum using positron emission tomographySynapse, 1992